S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Case Western Reserve University to Study Pluristem's PLX-RAD Cells in Umbilical Cord Blood Transplants for the Treatment of Blood Cancers and Genetic Diseases|
|Pluristem and Hadassah Medical Center Will Collaborate to Study Potential of PLX-RAD Cells to Improve Bone Marrow and Umbilical Cord Blood Transplant Outcomes|
|United Therapeutics Advances to Second Cohort in Phase I Trial of Pluristem's PLX-PAD Cells for Treatment of Pulmonary Arterial Hypertension|
|Avago Technologies Limited Announces Third Quarter Fiscal Year 2014 Financial Results|
|Pluristem Advances Its Second Major Cell Therapy Product Line From Development to Large-Scale Manufacturing|
|Avago Technologies Limited Announces Fourth Quarter and Fiscal Year 2014 Financial Results|
|Pluristem Granted Patents in Australia and New Zealand for Use of Placental Cells in the Treatment of Multiple Indications|
|Coverage Initiation Report Focuses on Pluristem Therapeutics|
|Avago Advanced SAS Storage Technology Powers Over 250 Next-Generation Server Models Using Latest Intel(R) Xeon(R) Processors|
|Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market|
Click above to view more mutual fund data and stats for plx - Protalix BioTherapeutics Inc.